Vicinitas Therapeutics
PrivateLast Round
Series A
Jul 28, 2022
Total Funding Raised
$65M
Company Overview
Vicinitas Therapeutics operates in Healthcare & Life Sciences and is based in South San Francisco, California. Its latest recorded funding round was a Series A round in July 2022.
Vicinitas Therapeutics is a biotechnology company that develops novel therapeutics for cancer and genetic disorders using its proprietary Deubiquitinase Targeting Chimeras (DUBTACs) protein stabilization platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vicinitas Therapeutics Comparables
Compare Vicinitas Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Stablix | 93% | |
| Lofty | 89% | |
| Easy Agent PRO | 84% |
For institutional investors. Book with your work email.
Vicinitas Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Vicinitas Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series A |
| Deerfield Management | Series A |
| GV | Series A |
| Droia Ventures | Series A |
| Berkeley Catalyst Fund | Series A |
| The Mark Foundation for Cancer Research | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2022
$65M round led by Andreessen Horowitz and Deerfield Management.
For institutional investors. Book with your work email.
Vicinitas Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Vicinitas Therapeutics's valuation, stock price, and market status.
Is Vicinitas Therapeutics a public or private company?
Vicinitas Therapeutics is a private company.
What is the current stock price of Vicinitas Therapeutics?
Vicinitas Therapeutics is a private company, so its shares have no public market price. Caplight tracks Vicinitas Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Vicinitas Therapeutics worth (valuation)?
Valuation information for Vicinitas Therapeutics is not publicly available.
Can I buy Vicinitas Therapeutics stock?
Vicinitas Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Vicinitas Therapeutics's last funding round?
Vicinitas Therapeutics's most recent funding round was Series A on July 28, 2022.
Who are the main investors in Vicinitas Therapeutics?
Key investors in Vicinitas Therapeutics include Andreessen Horowitz, Deerfield Management.
Will Vicinitas Therapeutics IPO soon?
No public IPO plans have been announced for Vicinitas Therapeutics.
How can I track Vicinitas Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Vicinitas Therapeutics's shares on secondary markets.